Cyanide Antidotes in Development and New Methods to Monitor Cyanide Toxicity

Matthew Brenner, Sari Mahon-Brenner, Steven Patterson, Gary A. Rockwood, Gerry R. Boss

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Currently approved treatments for cyanide poisoning in the United States are hydroxocobalamin and the combination of sodium nitrite and sodium thiosulfate. All three agents must be given in relatively large volumes by intravenous injection. This chapter presents data on three drugs in development that are sufficiently potent and soluble to be administered in small volumes. The three drugs are cobinamide, a cyanide scavenger, dimethyltrisulfide (DMTS), a sulfur donor and a possible substrate for the two cyanide detoxifying enzymes rhodanese and 3-mercaptopyruvate sulfurtransferase (3-MPST), and sulfanegen, a 3-MPST substrate. Laboratory methods to detect cyanide poisoning in acute clinical care settings have been limited by the need for complex and time consuming assays. The potential clinical role for measuring exhaled breath hydrogen cyanide remains to be determined, and further investigations are ongoing regarding simplified detection methods.

Original languageEnglish (US)
Title of host publicationToxicology of Cyanides and Cyanogens
Subtitle of host publicationExperimental, Applied and Clinical Aspects
PublisherWiley Blackwell
Pages309-316
Number of pages8
ISBN (Electronic)9781118628966
ISBN (Print)9781119978534
DOIs
StatePublished - Mar 5 2016

Fingerprint

Antidotes
Cyanides
Poisoning
Hydroxocobalamin
Thiosulfate Sulfurtransferase
Hydrogen Cyanide
Sodium Nitrite
Sulfur
Intravenous Injections
Pharmaceutical Preparations
Enzymes
3-mercaptopyruvic acid
Therapeutics

Keywords

  • Cobinamide
  • Cyanide antidotes
  • Cyanide toxicity
  • Sulfanegen

Cite this

Brenner, M., Mahon-Brenner, S., Patterson, S., Rockwood, G. A., & Boss, G. R. (2016). Cyanide Antidotes in Development and New Methods to Monitor Cyanide Toxicity. In Toxicology of Cyanides and Cyanogens: Experimental, Applied and Clinical Aspects (pp. 309-316). Wiley Blackwell. https://doi.org/10.1002/9781118628966.ch26

Cyanide Antidotes in Development and New Methods to Monitor Cyanide Toxicity. / Brenner, Matthew; Mahon-Brenner, Sari; Patterson, Steven; Rockwood, Gary A.; Boss, Gerry R.

Toxicology of Cyanides and Cyanogens: Experimental, Applied and Clinical Aspects. Wiley Blackwell, 2016. p. 309-316.

Research output: Chapter in Book/Report/Conference proceedingChapter

Brenner, M, Mahon-Brenner, S, Patterson, S, Rockwood, GA & Boss, GR 2016, Cyanide Antidotes in Development and New Methods to Monitor Cyanide Toxicity. in Toxicology of Cyanides and Cyanogens: Experimental, Applied and Clinical Aspects. Wiley Blackwell, pp. 309-316. https://doi.org/10.1002/9781118628966.ch26
Brenner M, Mahon-Brenner S, Patterson S, Rockwood GA, Boss GR. Cyanide Antidotes in Development and New Methods to Monitor Cyanide Toxicity. In Toxicology of Cyanides and Cyanogens: Experimental, Applied and Clinical Aspects. Wiley Blackwell. 2016. p. 309-316 https://doi.org/10.1002/9781118628966.ch26
Brenner, Matthew ; Mahon-Brenner, Sari ; Patterson, Steven ; Rockwood, Gary A. ; Boss, Gerry R. / Cyanide Antidotes in Development and New Methods to Monitor Cyanide Toxicity. Toxicology of Cyanides and Cyanogens: Experimental, Applied and Clinical Aspects. Wiley Blackwell, 2016. pp. 309-316
@inbook{524d115f6ffd4c8b8ec7cd6eb7340256,
title = "Cyanide Antidotes in Development and New Methods to Monitor Cyanide Toxicity",
abstract = "Currently approved treatments for cyanide poisoning in the United States are hydroxocobalamin and the combination of sodium nitrite and sodium thiosulfate. All three agents must be given in relatively large volumes by intravenous injection. This chapter presents data on three drugs in development that are sufficiently potent and soluble to be administered in small volumes. The three drugs are cobinamide, a cyanide scavenger, dimethyltrisulfide (DMTS), a sulfur donor and a possible substrate for the two cyanide detoxifying enzymes rhodanese and 3-mercaptopyruvate sulfurtransferase (3-MPST), and sulfanegen, a 3-MPST substrate. Laboratory methods to detect cyanide poisoning in acute clinical care settings have been limited by the need for complex and time consuming assays. The potential clinical role for measuring exhaled breath hydrogen cyanide remains to be determined, and further investigations are ongoing regarding simplified detection methods.",
keywords = "Cobinamide, Cyanide antidotes, Cyanide toxicity, Sulfanegen",
author = "Matthew Brenner and Sari Mahon-Brenner and Steven Patterson and Rockwood, {Gary A.} and Boss, {Gerry R.}",
year = "2016",
month = "3",
day = "5",
doi = "10.1002/9781118628966.ch26",
language = "English (US)",
isbn = "9781119978534",
pages = "309--316",
booktitle = "Toxicology of Cyanides and Cyanogens",
publisher = "Wiley Blackwell",
address = "Japan",

}

TY - CHAP

T1 - Cyanide Antidotes in Development and New Methods to Monitor Cyanide Toxicity

AU - Brenner, Matthew

AU - Mahon-Brenner, Sari

AU - Patterson, Steven

AU - Rockwood, Gary A.

AU - Boss, Gerry R.

PY - 2016/3/5

Y1 - 2016/3/5

N2 - Currently approved treatments for cyanide poisoning in the United States are hydroxocobalamin and the combination of sodium nitrite and sodium thiosulfate. All three agents must be given in relatively large volumes by intravenous injection. This chapter presents data on three drugs in development that are sufficiently potent and soluble to be administered in small volumes. The three drugs are cobinamide, a cyanide scavenger, dimethyltrisulfide (DMTS), a sulfur donor and a possible substrate for the two cyanide detoxifying enzymes rhodanese and 3-mercaptopyruvate sulfurtransferase (3-MPST), and sulfanegen, a 3-MPST substrate. Laboratory methods to detect cyanide poisoning in acute clinical care settings have been limited by the need for complex and time consuming assays. The potential clinical role for measuring exhaled breath hydrogen cyanide remains to be determined, and further investigations are ongoing regarding simplified detection methods.

AB - Currently approved treatments for cyanide poisoning in the United States are hydroxocobalamin and the combination of sodium nitrite and sodium thiosulfate. All three agents must be given in relatively large volumes by intravenous injection. This chapter presents data on three drugs in development that are sufficiently potent and soluble to be administered in small volumes. The three drugs are cobinamide, a cyanide scavenger, dimethyltrisulfide (DMTS), a sulfur donor and a possible substrate for the two cyanide detoxifying enzymes rhodanese and 3-mercaptopyruvate sulfurtransferase (3-MPST), and sulfanegen, a 3-MPST substrate. Laboratory methods to detect cyanide poisoning in acute clinical care settings have been limited by the need for complex and time consuming assays. The potential clinical role for measuring exhaled breath hydrogen cyanide remains to be determined, and further investigations are ongoing regarding simplified detection methods.

KW - Cobinamide

KW - Cyanide antidotes

KW - Cyanide toxicity

KW - Sulfanegen

UR - http://www.scopus.com/inward/record.url?scp=84975267045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975267045&partnerID=8YFLogxK

U2 - 10.1002/9781118628966.ch26

DO - 10.1002/9781118628966.ch26

M3 - Chapter

SN - 9781119978534

SP - 309

EP - 316

BT - Toxicology of Cyanides and Cyanogens

PB - Wiley Blackwell

ER -